# Tiofarma B.V. – FDA Inspection, Sep 22, 2023

Source: https://www.keypedia.com/records/fda_inspections/tiofarma-bv/d7b8630b-e3ab-496b-92c0-855f13d6e0eb
Source feed: FDA_Inspections

> FDA inspection 1222626 of Tiofarma B.V., September 22, 2023. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1222626
- Company Name: Tiofarma B.V.
- Inspection Date: 2023-09-22
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1204381 - 2021-07-06](https://www.keypedia.com/records/fda_inspections/tiofarma-bv/206b2b27-e7f9-48bd-a96e-aac49ed70049)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/samir-c-gala/904c34ee-013d-4663-a87a-9cbdbcf2b40e)

Company: https://www.keypedia.com/companies/tiofarma-bv/469e9283-e83d-4a9e-9a24-da094a5f0d92

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c